While elegant studies in T lymphocytes have shown that CEACAM-1 engagement by the fusobacterial adhesin CbpF inhibits the T cell response and antitumor immunity [13,20,33], the consequences elicited by the same interaction on the tumor cell side remain largely uninvestigated. This evidence concerns the gene CEACAM1 and neoplasm.